Vinitha M. Kuruvilla
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, RNA Interference and Gene Delivery, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity(2019)622 cited
- → Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models(2020)138 cited
- → Nephroprotective Effects of Metformin in Diabetic Nephropathy(2016)131 cited
- → Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition(2021)71 cited
- → Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia(2022)60 cited
- → Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells(2022)42 cited
- → Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia(2021)33 cited
- → Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses(2024)30 cited
- → Mitochondrial Oxphos As Survival Mechanism of Minimal Residual AML Cells after Induction Chemotherapy : Survival Benefit By Complex I Inhibition with Iacs-010759(2019)17 cited
- → Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic–Resistant AML and AML Stem Cells(2022)16 cited